Mark Awad, MD, PhD

Mark Awad, MD, PhD

Medical Oncology

Contact Information

Office Phone Number





877-332-4294 (new)
617-632-6190 (established)


Mark Awad, MD, PhD

Dr. Mark Awad is an Associate Professor of Medicine at Harvard Medical School and the Associate Chief of the Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Institute. He received his undergraduate degree from Harvard University and his MD and PhD degrees from the Johns Hopkins School of Medicine. He completed his residency and chief residency at the Massachusetts General Hospital, and his medical oncology fellowship at the Dana-Farber Cancer Institute before joining the Dana-Farber faculty in 2014. His translational research focus is on identifying biomarkers of response and resistance to targeted therapies and immunotherapies in lung cancer. He is the principal investigator of several clinical trials for patients with thoracic malignancies and collaborates closely with laboratory-based investigators. His research has been published in journals such as the New England Journal of Medicine, the Journal of Clinical Oncology, Cancer Immunology Research, and the Journal of Thoracic Oncology. He is a recipient of the 2015 Young Investigator Award from the American Society of Clinical Oncology (ASCO), the 2015 Young Investigator Award from the International Association for the Society of Lung Cancer (IASLC), the 2017 Career Development Award from Conquer Cancer Foundation of ASCO, and the 2018 ALK Positive/LUNGevity Transformational Research Award.



Director of Clinical Research
Program Director, Advanced Fellowship in Thoracic Oncology
Associate Professor of Medicine, Harvard Medical School
Associate Chief of the Lowe Center for Thoracic Oncology


Clinical Interests

Immunotherapy, Lung cancer, Mesothelioma, Targeted therapies

Board Certification

  • Internal Medicine, 2011
  • Medical Oncology, 2014


  • Dana-Farber/Partners CancerCare, Hematology/Oncology


  • Massachusetts General Hospital, Chief Resident, Internal Medicine
  • Massachusetts General Hospital, Internal Medicine

Medical School

  • Johns Hopkins School of Medicine

Recent Awards

  • Young Investigator Award (YIA), American Society of Clinical Oncology (ASCO)


  • Young Investigator Award (YIA), International Association for the Study of Lung Cancer (IASLC)


  • Lung Cancer Developmental Research Award, Dana-Farber / Harvard Cancer Center


  • Koch Institute Expansion Bridge Grant Recipient



    Immunotherapies and Vaccine Development

    Dr. Awad's main area of research is on cancer immunotherapy and vaccine development.  He has been working with a number of laboratories to study the genetics and immune microenvironment of lung tumors in order to develop better immune therapies for cancer patients.  In addition, he conducts research on cancers whose growth is driven by mutations in genes such as RET, ROS1, and ALK, and he has been working to understand how these cancers acquire resistance to targeted therapies.


    Location Avtar

    Dana-Farber Cancer Institute

    450 Brookline Avenue Boston, MA 02215
    Get Directions

    Dana-Farber Cancer Institute

    Location Avtar

    Dana-Farber Cancer Institute

    450 Brookline Avenue Boston, MA 02215
    Get Direction
    42.3374, -71.1082

    Ratings and Comments

    Mark Awad, MD, PhD

    About Our Ratings

    Physician Star Rating Comment Block